Emodin ameliorates cartilage degradation in osteoarthritis by inhibiting NF-κB and Wnt/β-catenin signaling in-vitro and in-vivo

Silverwood, 2015, Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis, Osteoarthr. Cartil., 23, 507, 10.1016/j.joca.2014.11.019 Goldring, 2009, Cartilage homeostasis in health and rheumatic diseases, Arthritis Res. Ther., 11, 224, 10.1186/ar2592 Troeberg, 2012, Proteases involved in cartilage matrix degradation in osteoarthritis, Biochim. Biophys. Acta, 1824, 133, 10.1016/j.bbapap.2011.06.020 Burrage, 2006, Matrix metalloproteinases: role in arthritis, Front. Biosci., 11, 529, 10.2741/1817 Burrage, 2007, Molecular targets in osteoarthritis: metalloproteinases and their inhibitors, Curr. Drug Targets, 8, 293, 10.2174/138945007779940098 Apte, 2016, Anti-ADAMTS5 monoclonal antibodies: implications for aggrecanase inhibition in osteoarthritis, Biochem. J., 473, e1, 10.1042/BJ20151072 Glasson, 2004, Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice, Arthritis Rheum., 50, 2547, 10.1002/art.20558 Gendron, 2007, Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4, J. Biol. Chem., 282, 18294, 10.1074/jbc.M701523200 Klein, 2011, Physiology and pathophysiology of matrix metalloproteases, Amino Acids, 41, 271, 10.1007/s00726-010-0689-x Felson, 2007, The futility of current approaches to chondroprotection, Arthritis Rheum., 56, 1378, 10.1002/art.22526 Kim, 2005, Volatile constituents from the leaves of Polygonum cuspidatum S. et Z. and their anti-bacterial activities, Food Microbiol., 22, 139, 10.1016/j.fm.2004.01.016 M.L. Lin, Y.C. Lu, J.G. Chung, S.G. Wang, H.T. Lin, S.E. Kang, C.H. Tang, J.L. Ko, S.S. Chen, Down-regulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion, Mol. Carcinog. 49(9) (2010) 783–97. Kaneshiro, 2006, Anthraquinone derivative emodin inhibits tumor-associated angiogenesis through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation, Eur. J. Pharmacol., 553, 46, 10.1016/j.ejphar.2006.09.026 Alisi, 2012, Emodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats, Int. J. Mol. Sci., 13, 2276, 10.3390/ijms13022276 Suboj, 2012, Aloe emodin inhibits colon cancer cell migration/angiogenesis by downregulating MMP-2/9, RhoB and VEGF via reduced DNA binding activity of NF-kappaB, Eur. J. Pharm. Sci., 45, 581, 10.1016/j.ejps.2011.12.012 Sun, 2015, Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo, Oncol. Rep., 33, 338, 10.3892/or.2014.3585 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 Mankin, 1971, Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data, J. Bone Joint Surg. Am., 53, 523, 10.2106/00004623-197153030-00009 Cheng, 2012, Pharmaceutical therapy for osteoarthritis, PM R, 4, S82, 10.1016/j.pmrj.2012.02.009 Zhu, 2016, Emodin suppresses LPS-induced inflammation in RAW264.7 cells through a PPARgamma-dependent pathway, Int. Immunopharmacol., 34, 16, 10.1016/j.intimp.2016.02.014 Yang, 2014, Emodin inhibits LPS-induced inflammatory response by activating PPAR-gamma in mouse mammary epithelial cells, Int. Immunopharmacol., 21, 354, 10.1016/j.intimp.2014.05.019 Ha, 2011, Emodin inhibits proinflammatory responses and inactivates histone deacetylase 1 in hypoxic rheumatoid synoviocytes, Biol. Pharm. Bull., 34, 1432, 10.1248/bpb.34.1432 Kshirsagar, 2014, Anti-inflammatory and antiarthritic activity of anthraquinone derivatives in rodents, Int. J. Inflamm., 2014, 10.1155/2014/690596 Zhu, 2013, Therapeutic effect of emodin on collagen-induced arthritis in mice, Inflammation, 36, 1253, 10.1007/s10753-013-9663-6 Hwang, 2013, Emodin suppresses inflammatory responses and joint destruction in collagen-induced arthritic mice, Rheumatology (Oxford), 52, 1583, 10.1093/rheumatology/ket178 Verma, 2011, ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis, J. Cell. Biochem., 112, 3507, 10.1002/jcb.23298 Dancevic, 2014, Current and emerging therapeutic strategies for preventing inflammation and aggrecanase-mediated cartilage destruction in arthritis, Arthritis Res. Ther., 16, 429, 10.1186/s13075-014-0429-9 Zhong, 2013, Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-kappaB nuclear translocation, Int. Immunopharmacol., 17, 329, 10.1016/j.intimp.2013.06.027 Park, 2013, MicroRNA-127-5p regulates matrix metalloproteinase 13 expression and interleukin-1beta-induced catabolic effects in human chondrocytes, Arthritis Rheum., 65, 3141, 10.1002/art.38188 Ma, 2012, A Wnt/beta-catenin negative feedback loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes, Arthritis Rheum., 64, 2589, 10.1002/art.34425 Tortorella, 2001, The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation, Osteoarthr. Cartil., 9, 539, 10.1053/joca.2001.0427 Malfait, 2002, Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage, J. Biol. Chem., 277, 22201, 10.1074/jbc.M200431200 Song, 2007, Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5, Arthritis Rheum., 56, 575, 10.1002/art.22334 Majumdar, 2007, Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis, Arthritis Rheum., 56, 3670, 10.1002/art.23027 Murphy, 2002, Matrix metalloproteinases in arthritic disease, Arthritis Res., 4, S39, 10.1186/ar572 Takaishi, 2008, Joint diseases and matrix metalloproteinases: a role for MMP-13, Curr. Pharm. Biotechnol., 9, 47, 10.2174/138920108783497659 Makki, 2016, Histone deacetylase inhibitor vorinostat (SAHA) suppresses IL-1beta-induced matrix metallopeptidase-13 expression by inhibiting IL-6 in osteoarthritis chondrocyte, Am. J. Pathol., 186, 2701, 10.1016/j.ajpath.2016.06.010 Naito, 2012, Development of a neutralizing antibody specific for the active form of matrix metalloproteinase-13, Biochemistry, 51, 8877, 10.1021/bi301228d Hsu, 2004, Production of the chemokine eotaxin-1 in osteoarthritis and its role in cartilage degradation, J. Cell. Biochem., 93, 929, 10.1002/jcb.20239 Bigg, 2001, The inhibition of metalloproteinases as a therapeutic target in rheumatoid arthritis and osteoarthritis, Curr. Opin. Pharmacol., 1, 314, 10.1016/S1471-4892(01)00055-8 Ray, 2003, Induction of matrix metalloproteinase 1 gene expression is regulated by inflammation-responsive transcription factor SAF-1 in osteoarthritis, Arthritis Rheum., 48, 134, 10.1002/art.10706 Hongbin, 2004, Carboxymethylated chitin reduces MMP-1 expression in rabbit ACLT osteoarthritic cartilage, Ann. Rheum. Dis., 63, 369, 10.1136/ard.2002.001461 Zayed, 2008, Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2, Arthritis Rheum., 58, 3530, 10.1002/art.23958 Marcu, 2010, NF-kappaB signaling: multiple angles to target OA, Curr. Drug Targets, 11, 599, 10.2174/138945010791011938 Li, 2018, Emodin attenuates titanium particle-induced osteolysis and RANKL-mediated osteoclastogenesis through the suppression of IKK phosphorylation, Mol. Immunol., 96, 8, 10.1016/j.molimm.2018.02.008 Sassi, 2014, WNT signaling and chondrocytes: from cell fate determination to osteoarthritis physiopathology, J. Recept. Signal Transduct. Res., 34, 73, 10.3109/10799893.2013.863919 Sassi, 2014, The roles of canonical and non-canonical Wnt signaling in human de-differentiated articular chondrocytes, Biotech. Histochem., 89, 53, 10.3109/10520295.2013.819123 Corr, 2008, Wnt-beta-catenin signaling in the pathogenesis of osteoarthritis, Nat. Clin. Pract. Rheumatol., 4, 550, 10.1038/ncprheum0904 Yuasa, 2008, Wnt/beta-catenin signaling stimulates matrix catabolic genes and activity in articular chondrocytes: its possible role in joint degeneration, Lab. Investig., 88, 264, 10.1038/labinvest.3700747 W.J. Li, L.P. Tang, Y. Xiong, W.P. Chen, X.D. Zhou, Q.H. Ding, L.D. Wu, A possible mechanism in DHEA-mediated protection against osteoarthritis, Steroids 89 (2014) 20–6. Laverty, 2010, The OARSI histopathology initiative — recommendations for histological assessments of osteoarthritis in the rabbit, Osteoarthr. Cartil., 18, S53, 10.1016/j.joca.2010.05.029